Kidney diseases, including chronic kidney disease (CKD) and acute kidney injury (AKI), represent a major global public health burden. These diseases cause ...

Superhero fans can stream the '90s staple Mighty Morphin' Power Rangers, the underrated show Mutant X, and the short-lived ...

An international research team has identified a human protein, ANKLE1, as the first DNA-cutting enzyme (nuclease) in mammals ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

An evolutionary "trap" has haunted crested and marbled newts for 25 million years: Leiden researchers have uncovered a mysterious DNA error that should not be able to arise—yet persists all the same.

ProBioGen and Spica Therapeutics, a biotechnology company advancing pathogenic macrophage subset-targeted immunotherapies, ...

“We are thrilled to welcome Kathy to Tessera,” said Michael Severino, M.D., CEO. “Her extensive strategic and financial expertise, combined with deep sector knowledge, will be invaluable as we enter ...

A new study has developed a powerful computational method that can detect how genes interact with each other to influence ...

Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative proteins, and increasing investments in ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...